They may not have been able to agree on a deal thus far, but there’s one thing that Unilever, the consumer goods group, and GlaxoSmithKline, the drugs company, have in common. Both are facing the wrath of disgruntled shareholders, which have attacked the performance and approaches taken by their respective managements. It is in this context that Dame Emma Walmsley, GSK’s embattled chief executive, now has to deal with an unsolicited approach for her consumer healthcare division from her opposite number at Unilever, the equally beleaguered Alan Jope. SponsoredUnilever has confirmed reports that it approached GSK and Pfizer, which owns a minority stake in the consumer division, about a potential acquisition. The latest of three separate approaches made by Unilever came days before

Source: The Times January 17, 2022 11:32 UTC